C07J 7/004
Substituted in position 17 alfa
Official title: {substituted in position 17 alfa}
C07J7/004 (Substituted in position 17 alfa) appears on 118 US grants and 56 published applications in this corpus.
Search patents in C07J- Granted patents
- 118
- Published applications
- 56
- Assignees
- 67
- Inventors
- 249
- Latest grant
- 28 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 4 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 3 | 0 |
| 1981 | 5 | 0 |
| 1982 | 8 | 0 |
| 1983 | 1 | 0 |
| 1984 | 8 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 5 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 1 |
| 2013 | 2 | 4 |
| 2014 | 0 | 4 |
| 2015 | 1 | 4 |
| 2016 | 2 | 3 |
| 2017 | 5 | 2 |
| 2018 | 2 | 2 |
| 2019 | 1 | 7 |
| 2020 | 4 | 2 |
| 2021 | 2 | 6 |
| 2022 | 2 | 3 |
| 2023 | 3 | 4 |
| 2024 | 1 | 3 |
| 2025 | 0 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- C7, C12, and C16 substituted neuroactive steroids and their methods of use28 May 2024US 11,993,628 B2Sage Therapeutics, Inc.
- Method for preparing 16Alpha-hydroxyprednisolone4 Apr 2023US 11,618,766 B2Zhejiang Shenzhou Pharmaceutical Company Limited
- Ocular inserts comprising a covalently linked steroid dimer28 Mar 2023US 11,612,567 B2Ripple Therapeutics Corporation
- Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof3 Jan 2023US 11,542,298 B2Epirium Bio Inc.
- Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery22 Mar 2022US 11,280,795 B2Indiana University Research and Technology Corporation
- Dexamethasone prodrug compositions and uses thereof20 Aug 2026US 2026/0240776 A1Ripple Therapeutics Corporation
- Process For The Production Of 21-(Acetyloxy)-17-(Propionyloxy)-Pregn-4-Ene-3,20-Dione4 Jun 2026US 2026/0152524 A1Industriale Chimica S.R.L.
- C7, c12, and c16 substituted neuroactive steroids and their methods of use20 Mar 2025US 2025/0092084 A1Sage Therapeutics, Inc.
- Dexamethasone prodrug compositions and uses thereof13 Feb 2025US 2025/0049719 A1Ripple Therapeutics Corporation
- Use of st-type lipid compounds in preparation of nucleic acid delivery reagent and related product5 Sep 2024US 2024/0293551 A1Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
Most cited
By later US patents
- Process for the preparation of 17.alpha.-hydroxyprogesterones and corticoids from androstenes48US 4,041,055 AThe Upjohn Company · 1977
- 11 .beta.-substituted progesterone analogs47US 4,954,490 AResearch Triangle Institute · 1990
- 3-Keto-19-nor-.DELTA.4,9-steroids39US 4,477,445 ARoussel Uclaf · 1984
- 11 .beta.-substituted progesterone analogs39US 5,073,548 AResearch Triangle Institute · 1991
- Antiinflammatory dexamethasone 17.alpha.-cyclopropanecarboxylates with reduced systemic activity34US 5,063,222 ASS Pharmaceutical Co., Ltd. · 1991